Skystar Bio-Pharmaceutical CO (SKBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 42,484 | 33,587 | 52,788 | 47,556 | 33,778 |
| Cost of Goods | 20,993 | 15,095 | 26,563 | 22,012 | 16,521 |
| Gross Profit | 21,491 | 18,492 | 26,226 | 25,545 | 17,257 |
| Operating Expenses | 9,471 | 10,036 | 11,538 | 7,446 | 6,084 |
| Operating Income | 13,013 | 8,551 | 15,250 | 18,110 | 11,695 |
| Interest Expense | 613 | 765 | 141 | 59 | 63 |
| Other Income | 531 | 594 | 1,420 | -662 | -751 |
| Pre-tax Income | 12,932 | 8,381 | 16,529 | 17,389 | 10,881 |
| Income Tax | 2,401 | 2,168 | 2,871 | 3,298 | 2,029 |
| Net Income Continuous | 10,530 | 6,212 | 13,658 | 14,091 | 8,852 |
| Net Income | $10,530 | $6,212 | $13,658 | $14,091 | $8,852 |
| EPS Basic Total Ops | 1.38 | 0.83 | 1.90 | 1.98 | 1.65 |
| EPS Basic Continuous Ops | 1.38 | 0.83 | 1.90 | 1.98 | 1.65 |
| EPS Diluted Total Ops | 1.37 | 0.83 | 1.90 | 1.97 | 1.62 |
| EPS Diluted Continuous Ops | 1.38 | 0.83 | 1.90 | 1.97 | 1.62 |
| EPS Diluted Before Non-Recurring Items | 1.37 | 0.83 | 1.90 | N/A | N/A |
| EBITDA(a) | $14,727 | $9,988 | $17,122 | $19,381 | $12,474 |